Menopausal Hormone Therapy (MHT)
Chairs: T de Villiers and C Cooper
Members: J Cannata-Andia, HP Dimai, P Ebeling, J Foldes, P Hadji, K Javaid, JA Kanis, D Kendler, M McClung, R Rizzoli
To clarify the benefit-risk ratio of oestrogen/oestrogen-progesterone therapies on bone health in women.
To make recommendations on the role of MHT for prevention and treatment of postmenopausal osteoporosis.